Novoron’s History & Milestones
Sep 2021 - NIH Phase 1 grant to develop Alzheimer’s (tauopathies) therapy
Jul 2021 - Novoron closes seed round led by Two Bear Capital
Aug 2020 - Dr. Stiles named to NIH small business panel for aging & neurologic disorders
Jul 2019 - Dr. Stiles named to NIH/NINDS Special Emphasis Panel
Apr 2019 - Phase 1B NIH grant received to develop MS therapeutic.
May 2018 - Phase 1B NIH grant received to develop SCI therapeutic.
Oct 2017 - J&J names Dr. Stiles to Under 40 to Watch List: 6 Young Trailblazing Scientists.
Jun 2017 - Dr. Travis Stiles featured speaker at Neurotech 2017 in San Francisco.
Sep 2016 - Novoron finishes 3rd in RESI Innovation Challenge in Boston.
Sep 2016 - Dr. Travis Stiles receives 2016 Catalyst Award from Biocom.
May 2016 - Xconomy identifies Novoron as a life sciences startup to watch.
Sep 2015 - Phase 1 NIH grant received to develop MS therapeutic.
Jul 2015 - Novoron named a 2015 Cool Company by San Diego Venture Group.
Dec 2014 - Novoron leadership graduates from NIH's I-Corps.
Aug 2014 - Phase 1 NIH grants received to develop SCI and stroke therapeutics.
Feb 2014 - Novoron Bioscience incorporates.
Nov 2012 - Dr. Travis Stiles' discovery published in Journal of Cell Science.
